| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
|
JAMA
|
2009
|
7.78
|
|
2
|
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.
|
J Am Coll Cardiol
|
2012
|
4.45
|
|
3
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
|
Circulation
|
2007
|
2.37
|
|
4
|
Impact of the troponin standard on the prevalence of acute myocardial infarction.
|
Am Heart J
|
2003
|
2.02
|
|
5
|
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
|
J Am Coll Cardiol
|
2007
|
1.92
|
|
6
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
|
Clin Chem
|
2007
|
1.82
|
|
7
|
Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.
|
Am Heart J
|
2006
|
1.81
|
|
8
|
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency department.
|
Ann Emerg Med
|
2005
|
1.72
|
|
9
|
Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients.
|
J Am Coll Cardiol
|
2004
|
1.66
|
|
10
|
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.
|
Circulation
|
2007
|
1.62
|
|
11
|
The prevalence and outcomes of in-hospital acute myocardial infarction in the Department of Veterans Affairs Health System.
|
Arch Intern Med
|
2006
|
1.58
|
|
12
|
A comprehensive strategy for the evaluation and triage of the chest pain patient: a cost comparison study.
|
J Nucl Cardiol
|
2003
|
1.52
|
|
13
|
Sensitivity of acute rest myocardial perfusion imaging for identifying patients with myocardial infarction based on a troponin definition.
|
J Nucl Cardiol
|
2004
|
1.46
|
|
14
|
Caring for returning Veterans: meeting mental health needs.
|
J Clin Psychiatry
|
2013
|
1.39
|
|
15
|
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
|
Circulation
|
2007
|
1.39
|
|
16
|
Strategies from a nationwide health information technology implementation: the VA CART story.
|
J Gen Intern Med
|
2010
|
1.33
|
|
17
|
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.
|
Clin Chem
|
2007
|
1.19
|
|
18
|
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers.
|
Circulation
|
2005
|
1.13
|
|
19
|
Implication of the new low-density lipoprotein goals in dyslipidemia management of patients with acute coronary syndrome.
|
Mayo Clin Proc
|
2007
|
1.09
|
|
20
|
National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure.
|
Clin Chem
|
2007
|
1.08
|
|
21
|
Coronary angiographic findings in patients with cocaine-associated chest pain.
|
J Emerg Med
|
2003
|
1.07
|
|
22
|
The clinician as investigator: participating in clinical trials in the practice setting.
|
Circulation
|
2004
|
1.01
|
|
23
|
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
|
Circulation
|
2007
|
1.00
|
|
24
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
|
Clin Biochem
|
2007
|
0.93
|
|
25
|
Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.
|
Am Heart J
|
2007
|
0.92
|
|
26
|
On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction.
|
J Am Coll Cardiol
|
2010
|
0.90
|
|
27
|
Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes.
|
Arch Intern Med
|
2005
|
0.88
|
|
28
|
Mortality based on the presenting electrocardiogram in patients with myocardial infarction in the troponin era.
|
Am J Emerg Med
|
2009
|
0.86
|
|
29
|
Comparison of the modification of diet in renal disease and the Cockcroft-Gault equations for predicting mortality in patients admitted for exclusion of myocardial ischemia.
|
Am J Cardiol
|
2008
|
0.86
|
|
30
|
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
|
J Am Coll Cardiol
|
2006
|
0.85
|
|
31
|
Comparison of 2-dimensional echocardiography and myocardial perfusion imaging for diagnosing myocardial infarction in emergency department patients.
|
Am Heart J
|
2002
|
0.84
|
|
32
|
Improving healthcare systems' disclosures of large-scale adverse events: a Department of Veterans Affairs leadership, policymaker, research and stakeholder partnership.
|
J Gen Intern Med
|
2014
|
0.82
|
|
33
|
Feasibility of proactive medical device surveillance: the VA Clinical Assessment Reporting and Tracking (CART) program.
|
Med Care
|
2013
|
0.81
|
|
34
|
Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus.
|
Thromb Haemost
|
2002
|
0.80
|
|
35
|
Mental health needs of returning veterans.
|
J Clin Psychiatry
|
2013
|
0.80
|
|
36
|
Utility of troponin I in patients with cocaine-associated chest pain.
|
Acad Emerg Med
|
2002
|
0.80
|
|
37
|
Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke.
|
Circulation
|
2002
|
0.79
|
|
38
|
Predictive power of ejection fraction and renal failure in patients admitted for chest pain without ST elevation in the troponin era.
|
Am Heart J
|
2005
|
0.78
|
|
39
|
Outcomes in patients admitted for chest pain with renal failure and troponin I elevations.
|
Am Heart J
|
2005
|
0.77
|
|
40
|
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
|
Circulation
|
2004
|
0.77
|
|
41
|
Value of simultaneous functional assessment in association with acute rest perfusion imaging for predicting short- and long-term outcomes in emergency department patients with chest pain.
|
J Nucl Cardiol
|
2008
|
0.76
|
|
42
|
Commentary: building human capital: discovery, learning, and professional satisfaction.
|
Acad Med
|
2011
|
0.75
|
|
43
|
The current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk.
|
Rev Cardiovasc Med
|
2014
|
0.75
|
|
44
|
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
|
Circulation
|
2004
|
0.75
|
|
45
|
Power thrombectomy in acute ischemic coronary syndromes.
|
Angiology
|
2003
|
0.75
|
|
46
|
Myocardial salvage in patients with non-ST-elevation myocardial infarction determined by myocardial perfusion imaging.
|
Am J Cardiol
|
2005
|
0.75
|
|
47
|
Ability of myoglobin to predict mortality in patients admitted for exclusion of myocardial infarction.
|
Am J Emerg Med
|
2007
|
0.75
|
|
48
|
Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes.
|
Clin Chem
|
2002
|
0.75
|
|
49
|
Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.
|
Am Heart J
|
2002
|
0.75
|
|
50
|
Predictive power of systolic function and congestive heart failure in patients with patients admitted for chest pain without ST elevation in the troponin era.
|
Am Heart J
|
2008
|
0.75
|